SKIN-RESPONSES TO INTRADERMAL HISTAMINE AND LEUKOTRIENE-C4 LEUKOTRIENE-D4, AND LEUKOTRIENE-E4 IN PATIENTS WITH CHRONIC IDIOPATHIC URTICARIA AND IN NORMAL SUBJECTS

被引:52
作者
MAXWELL, DL [1 ]
ATKINSON, BA [1 ]
SPUR, BW [1 ]
LESSOF, MH [1 ]
LEE, TH [1 ]
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT ALLERGY & ALLIED RESP DISORDERS,LONDON SE1 9RT,ENGLAND
关键词
D O I
10.1016/S0091-6749(05)80180-0
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mast cell inflammatory mediators, such as histamine, and newly formed compounds, such as the leukotrienes, cause wheal and flare when they are injected intradermally into normal subjects and may therefore play a role in the formation of urticaria. The effects of intradermal injections (50 μl) of six different concentrations of histamine (range, 3.3×10-4 to 3.3×10-9 mol/L) and the leukotrienes C4, D4, and E4 (range, 2×10-4 to 2×10-9 mol/L) have been compared in 10 normal subjects and in 10 patients with chronic idiopathic urticaria. Wheal-and-flare sizes were measured at timed intervals up to 4 hours, and area under the curve for each response over time was calculated. There were no significant differenes in leukotriene-induced responses between groups. Maximum sizes of histamine-induced wheal and flare were similar in each group of subjects. There were, however, significant increases in mean areas under the response curve of histamine wheal and flare in the patients with urticaria (wheal, p<0.001; flare, p<0.001; analysis of variance). These findings demonstrate a prolongation of skin responses to histamine in patients with urticaria and suggest an impaired clearance of histamine (or other vasoactive agents released by histamine) from the skin of these patients. © 1990 Mosby-Year Book, Inc.
引用
收藏
页码:759 / 765
页数:7
相关论文
共 16 条
[1]   THE EFFECTS OF ASTEMIZOLE ON HISTAMINE-INDUCED WEAL AND FLARE [J].
BATEMAN, DN ;
CHAPMAN, PH ;
RAWLINS, MD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (04) :547-551
[2]   INCREASED COMPOUND 48/80 INDUCED LOCAL HISTAMINE-RELEASE FROM NONLESIONAL SKIN OF PATIENTS WITH CHRONIC URTICARIA [J].
BEDARD, PM ;
BRUNET, C ;
PELLETIER, G ;
HEBERT, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 78 (06) :1121-1125
[3]  
BRUENT C, 1988, J ALLERGY CLIN IMMUN, V82, P398
[4]   RESPONSES OF HUMAN-SKIN TO INTRADERMAL INJECTION OF LEUKOTRIENE-C4, LEUKOTRIENE-D4 AND LEUKOTRIENE-B4 [J].
CAMP, RDR ;
COUTTS, AA ;
GREAVES, MW ;
KAY, AB ;
WALPORT, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 80 (03) :497-502
[5]   DISCRIMINATION BETWEEN URTICARIA-PRONE AND OTHER ALLERGIC PATIENTS BY INTRADERMAL SKIN TESTING WITH CODEINE [J].
COHEN, RW ;
ROSENSTREICH, DL .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (06) :802-807
[6]   HISTAMINE WEAL FORMATION AND ABSORPTION IN MAN [J].
COOK, J ;
SHUSTER, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 69 (04) :579-585
[7]  
JUHLIN L, 1969, ACTA DERM-VENEREOL, V49, P26
[8]   ASSESSMENT OF TISSUE FLUID HISTAMINE LEVELS IN PATIENTS WITH URTICARIA [J].
KAPLAN, AP ;
HORAKOVA, Z ;
KATZ, SI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1978, 61 (06) :350-354
[9]  
KRAUSE LB, 1985, BR J CLIN PHARM, V20, P468
[10]  
LESSOF MH, 1989, PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, P353